Advisory Research’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,406
Closed -$329K 410
2021
Q1
$329K Sell
8,406
-52,178
-86% -$2.45M 0.02% 300
2020
Q4
$2.64M Buy
+60,584
New +$2.07M 0.19% 101
2020
Q3
Sell
-89,338
Closed -$3.25M 349
2020
Q2
$3.25M Buy
89,338
+64,723
+263% +$1.82M 0.29% 86
2020
Q1
$447K Buy
+24,615
New +$540K 0.03% 204

Other funds holding ONEM

Advisory Research's ONEM Position: Q2 2021 in Review

Advisory Research sold out of 1Life Healthcare (ONEM) in Q2 2021, closing a stake of 8,406 shares — an estimated $329K sold.

Advisory Research first reported a position in ONEM in Q1 2020 and held it in 4 quarters. The position peaked at $3.25M in Q2 2020. 220 funds tracked by Wall St. Rank hold ONEM as of Q2 2021.

  • Advisory Research reported no remaining 1Life Healthcare position as of Q2 2021 after selling out during the quarter.
  • Advisory Research sold 8,406 1Life Healthcare shares in Q2 2021, an estimated $329K.
  • Advisory Research first reported a position in 1Life Healthcare in Q1 2020 and held it in 4 quarters.
  • Advisory Research's 1Life Healthcare position peaked at $3.25M in Q2 2020.
  • 220 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2021.

Based on Advisory Research's 13F filing for Q2 2021, filed 16 Aug 2021.